Try our Advanced Search for more refined results

Amgen To Pay $25M To Escape Anemia Drug Kickback Suit

By Max Stendahl (April 16, 2013, 6:50 PM EDT) -- Amgen Inc., which pled guilty in December to misbranding its Aranesp anemia drug, will pay $24.9 million to settle a whistleblower suit alleging it paid kickbacks to pharmacy providers to promote the drug among Medicare and Medicaid patients, the U.S. Department of Justice said Tuesday....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!